The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 5,184 | 6,020,770 | SH | SOLE | 6,020,770 | 0 | 0 | ||
| UIPATH INC | CL A | 90364P105 | 6,259 | 607,673 | SH | SOLE | 607,673 | 0 | 0 | ||
| SNOWFLAKE INC | CL A | 833445109 | 17,044 | 116,610 | SH | SOLE | 116,610 | 0 | 0 | ||